TI
ADMA icon

Tidal Investments’s ADMA Biologics ADMA Stock Holding History

Tidal Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
+17,660
New +$161K ﹤0.01% 2504
2025
Q3 		– Sell
-15,658
Closed -$285K – 2041
2025
Q2 		$285K Sell
15,658
-4,777
-23% -$97.4K ﹤0.01% 1651
2025
Q1 		$405K Sell
20,435
-9,916
-33% -$171K ﹤0.01% 1420
2024
Q4 		$521K Sell
30,351
-7,983
-21% -$150K ﹤0.01% 1361
2024
Q3 		$766K Sell
38,334
-33,710
-47% -$524K 0.01% 1144
2024
Q2 		$805K Buy
+72,044
New +$604K 0.01% 1017

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Tidal Investments's ADMA Position: Q2 2026 in Review

Tidal Investments opened a new position in ADMA Biologics (ADMA) in Q2 2026: 17,660 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #2504 among its holdings. This is a return to the name: Tidal Investments previously reported a position in ADMA as recently as Q2 2025.

Tidal Investments first reported a position in ADMA in Q2 2024 and has held it in 6 quarters since. The position peaked at $805K in Q2 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Tidal Investments held 17,660 shares of ADMA Biologics worth $148K as of Q2 2026.
  • ADMA Biologics was a new Tidal Investments position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2504 holding.
  • Tidal Investments first reported a position in ADMA Biologics in Q2 2024 and has held it in 6 quarters since.
  • Tidal Investments's ADMA Biologics position peaked at $805K in Q2 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.